Literature DB >> 6712541

Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits.

S Yokoyama, R Hayashi, T Kikkawa, N Tani, S Takada, K Hatanaka, A Yamamoto.   

Abstract

Dextran sulfate was covalently bound to cellulose beads (LA01) and used as the specific sorbent of apolipoprotein B-containing lipoproteins. The binding profiles of very low density, low density, and high density lipoproteins to the material were consistent with simple Langmuir adsorption isotherms. Although the affinities of all lipoproteins for the sorbent were roughly similar, the surface area available for high density lipoprotein binding was much smaller than that for very low and low density lipoproteins (29, 927, and 1934 m2/liter of swollen beads, respectively). When human plasma was passed through a sorbent column, very low and low density lipoproteins were selectively adsorbed, while almost all the high density lipoproteins were recovered from the column together with the other major plasma components. An extracorporeal circulation system with this sorbent was used for the treatment of hypercholesterolemic rabbits (diet-induced and homozygous WHHL). With a 25 ml sorbent column, very low and low density lipoproteins were selectively removed from rabbit plasma, resulting in a reduction of plasma cholesterol concentration by 300 mg/dl.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712541     DOI: 10.1161/01.atv.4.3.276

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  8 in total

Review 1.  Lipoprotein apheresis to treat elevated lipoprotein (a).

Authors:  Elisa Waldmann; Klaus G Parhofer
Journal:  J Lipid Res       Date:  2016-02-17       Impact factor: 5.922

2.  Integrated Dual-Mode Chromatography to Enrich Extracellular Vesicles from Plasma.

Authors:  Jan Van Deun; Ala Jo; Huiyan Li; Hsing-Ying Lin; Ralph Weissleder; Hyungsoon Im; Hakho Lee
Journal:  Adv Biosyst       Date:  2020-04-30

3.  Effect of LDL-apheresis on the pharmacokinetics of the lipophilic antilipidemic agent probucol.

Authors:  T Komura; K Takahara; M Sugano; A Fujinishi; H Tasaki; Y Nakashima; A Kuroiwa
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.441

4.  Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.

Authors:  G R Thompson; J P Miller; J L Breslow
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-14

5.  Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis.

Authors:  M Hattori; K Ito; H Kawaguchi; T Tanaka; R Kubota; M Khono
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

6.  Successful treatment of homozygous familial hypercholesterolemia using cascade filtration plasmapheresis.

Authors:  Fatih Kardaş; Aysun Cetin; Musa Solmaz; Rüksan Büyükoğlan; Leylagül Kaynar; Mustafa Kendirci; Bülent Eser; Ali Unal
Journal:  Turk J Haematol       Date:  2011-04-01       Impact factor: 1.831

7.  Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia.

Authors:  Katherine D Connolly; Gareth R Willis; Dev B N Datta; Elizabeth A Ellins; Kristin Ladell; David A Price; Irina A Guschina; D Aled Rees; Philip E James
Journal:  J Lipid Res       Date:  2014-08-13       Impact factor: 5.922

8.  Role of lipid apheresis in changing times.

Authors:  Peter Schuff-Werner; Sebastian Fenger; Peter Kohlschein
Journal:  Clin Res Cardiol Suppl       Date:  2012-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.